CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer: a single institute pilot study

被引:3
作者
Fodor, Andrei [1 ]
Mori, Martina [2 ]
Tummineri, Roberta [1 ]
Broggi, Sara [2 ]
Deantoni, Chiara Lucrezia [1 ]
Mangili, Paola [2 ]
Baroni, Simone [1 ]
Villa, Stefano Lorenzo [1 ]
Dell'Oca, Italo [1 ]
Del Vecchio, Antonella [2 ]
Fiorino, Claudio [2 ]
Di Muzio, Nadia [1 ,3 ]
机构
[1] IRCCS San Raffaele Sci Inst, Dept Radiat Oncol, 60 Olgettina St, I-20132 Milan, Italy
[2] IRCCS San Raffaele Sci Inst, Med Phys, Milan, Italy
[3] Univ Vita Salute San Raffaele, Milan, Italy
关键词
Radiomic features (RFs); Planning computed tomography (CT); Radical radiotherapy; Local control thoracic metastases; Colorectal tumors; RADIATION-THERAPY SBRT; DELINEATION; FEATURES; ROBUST; TRIAL;
D O I
10.1007/s00066-022-02034-w
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: To assess the potential of radiomic features (RFs) extracted from simulation computed tomography (CT) images in discriminating local progression (LP) after stereotactic body radiotherapy (SBRT) in the management of lung oligometastases (LOM) from colorectal cancer (CRC). Materials and methods: Thirty-eight patients with 70 LOM treated with SBRT were analyzed. The largest LOM was considered as most representative for each patient and was manually delineated by two blinded radiation oncologists. In all, 141 RFs were extracted from both contours according to IBSI (International Biomarker Standardization Initiative) recommendations. Based on the agreement between the two observers, 134/141 RFs were found to be robust against delineation (intraclass correlation coefficient [ICC] > 0.80); independent RFs were then assessed by Spearman correlation coefficients. The association between RFs and LP was assessed with Mann-Whitney test and univariate logistic regression (ULR): the discriminative power of the most informative RF was quantified by receiver-operating characteristics (ROC) analysis through area under curve (AUC). Results: In all, 15/38 patients presented LP. Median time to progression was 14.6 months (range 2.4-66 months); 5/141 RFs were significantly associated to LP at ULR analysis (p < 0.05); among them, 4 RFs were selected as robust and independent: Statistical_Variance (AUC = 0.75, p = 0.002), Statistical_Range (AUC = 0.72, p = 0.013), Grey Level Size Zone Matrix (GLSZM) _zoneSizeNonUniformity (AUC = 0.70, p = 0.022), Grey Level Dependence Zone Matrix (GLDZM) _zoneDistanceEntropy (AUC = 0.70, p = 0.026). Importantly, the RF with the best performance (Statisical_Variance) is simply representative of density heterogeneity within LOM. Conclusion: Four RFs extracted from planning CT were significantly associated with LP of LOM from CRC treated with SBRT. Results encourage further research on a larger population aiming to define a usable radiomic score combining the most predictive RFs and, possibly, additional clinical features.
引用
收藏
页码:477 / 484
页数:8
相关论文
共 36 条
  • [1] Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution
    Abbosh, Christopher
    Birkbak, Nicolai J.
    Wilson, Gareth A.
    Jamal-Hanjani, Mariam
    Constantin, Tudor
    Salari, Raheleh
    Le Quesne, John
    Moore, David A.
    Veeriah, Selvaraju
    Rosenthal, Rachel
    Marafioti, Teresa
    Kirkizlar, Eser
    Watkins, Thomas B. K.
    McGranahan, Nicholas
    Ward, Sophia
    Martinson, Luke
    Riley, Joan
    Fraioli, Francesco
    Al Bakir, Maise
    Gronroos, Eva
    Zambrana, Francisco
    Endozo, Raymondo
    Bi, Wenya Linda
    Fennessy, Fiona M.
    Sponer, Nicole
    Johnson, Diana
    Laycock, Joanne
    Shafi, Seema
    Czyzewska-Khan, Justyna
    Rowan, Andrew
    Chambers, Tim
    Matthews, Nik
    Turajlic, Samra
    Hiley, Crispin
    Lee, Siow Ming
    Forster, Martin D.
    Ahmad, Tanya
    Falzon, Mary
    Borg, Elaine
    Lawrence, David
    Hayward, Martin
    Kolvekar, Shyam
    Panagiotopoulos, Nikolaos
    Janes, Sam M.
    Thakrar, Ricky
    Ahmed, Asia
    Blackhall, Fiona
    Summers, Yvonne
    Hafez, Dina
    Naik, Ashwini
    [J]. NATURE, 2017, 545 (7655) : 446 - +
  • [2] Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
    Aerts, Hugo J. W. L.
    Velazquez, Emmanuel Rios
    Leijenaar, Ralph T. H.
    Parmar, Chintan
    Grossmann, Patrick
    Cavalho, Sara
    Bussink, Johan
    Monshouwer, Rene
    Haibe-Kains, Benjamin
    Rietveld, Derek
    Hoebers, Frank
    Rietbergen, Michelle M.
    Leemans, C. Rene
    Dekker, Andre
    Quackenbush, John
    Gillies, Robert J.
    Lambin, Philippe
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [3] Combining computed tomography and biologically effective dose in radiomics and deep learning improves prediction of tumor response to robotic lung stereotactic body radiation therapy
    Avanzo, Michele
    Gagliardi, Vito
    Stancanello, Joseph
    Blanck, Oliver
    Pirrone, Giovanni
    El Naqa, Issam
    Revelant, Alberto
    Sartor, Giovanna
    [J]. MEDICAL PHYSICS, 2021, 48 (10) : 6257 - 6269
  • [4] Radiogenomics-based cancer prognosis in colorectal cancer
    Badic, Bogdan
    Hatt, Mathieu
    Durand, Stephanie
    Le Jossic-Corcos, Catherine
    Simon, Brigitte
    Visvikis, Dimitris
    Corcos, Laurent
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] The Rise in Metastasectomy Across Cancer Types Over the Past Decade
    Bartlett, Edmund K.
    Simmons, Kristina D.
    Wachtel, Heather
    Roses, Robert E.
    Fraker, Douglas L.
    Kelz, Rachel R.
    Karakousis, Giorgos C.
    [J]. CANCER, 2015, 121 (05) : 747 - 757
  • [6] Quantifying the robustness of [18F]FDG-PET/CT radiomic features with respect to tumor delineation in head and neck and pancreatic cancer patients
    Belli, Maria Luisa
    Mori, Martina
    Broggi, Sara
    Cattaneo, Giovanni Mauro
    Bettinardi, Valentino
    Dell'Oca, Italo
    Fallanca, Federico
    Passoni, Paolo
    Vanoli, Emilia Giovanna
    Calandrino, Riccardo
    Di Muzio, Nadia
    Picchio, Maria
    Fiorino, Claudio
    [J]. PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2018, 49 : 105 - 111
  • [7] Primary Study Endpoint Analysis for NRG Oncology/RTOG 0813 Trial of Stereotactic Body Radiation Therapy (SBRT) for Centrally Located Non-Small Cell Lung Cancer (NSCLC)
    Bezjak, A.
    Paulus, R.
    Gaspar, L. E.
    Timmerman, R. D.
    Straube, W. L.
    Ryan, W. F.
    Garces, Y.
    Pu, A. T.
    Singh, A. K.
    Videtic, G. M.
    McGarry, R. C.
    Iyengar, P.
    Pantarotto, J. R.
    Urbanic, J. J.
    Sun, A.
    Daly, M. E.
    Grills, I. S.
    Normolle, D. P.
    Bradley, J. D.
    Choy, H.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 94 (01): : 5 - 6
  • [8] Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with "curative" intent
    Buglione, Michela
    Jereczek-Fossa, Barbara Alicja
    Bonu, Marco Lorenzo
    Franceschini, Davide
    Fodor, Andrei
    Zanetti, Isa Bossi
    Gerardi, Marianna Alessandra
    Borghetti, Paolo
    Tomasini, Davide
    Di Muzio, Nadia Gisella
    Oneta, Olga
    Scorsetti, Marta
    Franzese, Ciro
    Romanelli, Paola
    Catalano, Giampiero
    Dell'Oca, Italo
    Beltramo, Giancarlo
    Ivaldi, Giovanni Battista
    Laudati, Antonio
    Magrini, Stefano Maria
    Antognoni, Paolo
    [J]. LUNG CANCER, 2020, 141 : 1 - 8
  • [9] Comparison of radiomic feature aggregation methods for patients with multiple tumors
    Chang, Enoch
    Joel, Marina
    Chang, Hannah Y.
    Du, Justin
    Khanna, Omaditya
    Omuro, Antonio
    Chiang, Veronica
    Aneja, Sanjay
    [J]. SCIENTIFIC REPORTS, 2021, 11 (01)
  • [10] Identification of Non-Small Cell Lung Cancer Sensitive to Systemic Cancer Therapies Using Radiomics
    Dercle, Laurent
    Fronheiser, Matthew
    Lu, Lin
    Du, Shuyan
    Hayes, Wendy
    Leung, David K.
    Roy, Amit
    Wilkerson, Julia
    Guo, Pingzhen
    Fojo, Antonio T.
    Schwartz, Lawrence H.
    Zhao, Binsheng
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (09) : 2151 - 2162